Stock Forecast Chart
Stock Price Prediction Summary
Forecast Score Based on 2 Weeks
Based on our forecast, the price of LXEO will decline by -3.02% over the next 2 Weeks and hit $4.22 by Thursday, August 13, 2026. In that time frame, LXEO's share price is expected to range between $3.97 and $4.48.
BearishAverageBullish| Date | Predicted Lower | Predicted | Predicted Upper |
|---|---|---|---|
| Aug 13, 2026 | 3.97 | 4.22 | 4.48 |
| Aug 12, 2026 | 4.03 | 4.28 | 4.53 |
| Aug 11, 2026 | 3.95 | 4.20 | 4.45 |
| Aug 10, 2026 | 3.95 | 4.21 | 4.46 |
| Aug 7, 2026 | 3.98 | 4.22 | 4.48 |
| Aug 6, 2026 | 4.03 | 4.26 | 4.51 |
| Aug 5, 2026 | 4.07 | 4.32 | 4.55 |
| Aug 4, 2026 | 4.00 | 4.24 | 4.50 |
| Aug 3, 2026 | 3.99 | 4.25 | 4.50 |
| Jul 31, 2026 | 4.01 | 4.26 | 4.51 |
LXEO shares fell -5.06% in Friday, July 31, 2026's trading session, dropping from a previous close of $4.35 to move at $4.13. The stock demonstrated notable intraday movement (see LXEO's key stats for a full breakdown), fluctuating between $4.07 and $4.38, a +7.62% trading range. While recent weeks have seen some volatility, LXEO has managed to secure a -9.23% drop over the past 2 weeks. The downward price movement was accompanied by increased trading volume, with approximately 713.56K shares changing hands, 68.93K more than the previous session. This amounted to $2.95M in total market activity.
Will LXEO Continue Its Upward Trend?
According to analyst ratings and projections for LXEO, Lexeo Therapeutics, Inc. Common Stock shares are anticipated to increase by +7.83%, potentially reaching $4.48 per share by August 13, 2026. Short-term technical indicators currently suggest a neutral sentiment for LXEO. For deeper insights, view our sentiment analysis on AAPL covering social and institutional perspectives. However, the stock has recorded 11 positive trading days within the past 30 sessions. Based on the LXEO stock forecast, now is a good time to buy LXEO stock because its current trading price is -2.10% below our predicted value, hinting at a possible overvaluation. For deeper insights, view our sentiment analysis on LXEO covering social and institutional perspectives.
LXEO Technical Momentum: Overbought, Oversold, or Neutral?
An analysis of Relative Strength Index (RSI) indicators provides insight into LXEO's momentum. Short-term RSIs (9, 14, and 20-day figures ranging from 31.46% to 39.80%) suggest the stock is in a weak bearish momentum phase. The 50-day RSI, at 43.15%, suggests a neutral medium-term outlook. Additionally, the 100-day RSI, at 45.68%, maintains a neutral outlook for the long term. Insights into LXEO's shareholder base show how institutional investors are positioning themselves during these momentum shifts
Lexeo Therapeutics Common Stock Short-Term Forecasts
LXEO Forecast For Next 5 Days
Our algorithm anticipates Lexeo Therapeutics Common Stock (LXEO) stock could hit $4.28 by Aug 07, 2026. This represents a +3.51% fall from today's price, following a -10.59% change over the past five days.
LXEO Forecast For Next 30 Days
Based on analysis of market trends, the outlook for Lexeo Therapeutics, Inc. Common Stock (LXEO) stock over the next 30 days is largely positive. Price forecasts suggest an average target of $4.26, which would mean a +3.15% increase from the current price of $4.13. Projections for this period range from a high of $5.10 to a low of $3.52.
LXEO Forecast For Next 90 Days
Our proprietary market analysis suggests predictions for Lexeo Therapeutics Common Stock's price over the next three months point to a rise. LXEO stock is expected to peak at $8.95 on Jul 31, 2026 before potentially dipping to $6.00 on Oct 30, 2026. On average, LXEO is likely to trade around $7.38 in the coming 90 days.
Lexeo Therapeutics Common Stock Stock Forecast 2025
Based on our predictive models, Lexeo Therapeutics Common Stock (LXEO) is expected to trade between $4.87 and $8.95 throughout 2026. This would result in an average price of $7.20, potentially offering investors a +74.33% return from current levels.
Lexeo Therapeutics, Inc. Common Stock Monthly Forecast 2026–2027
July 2026
According to our latest forecast models, Lexeo Therapeutics, Inc. Common Stock (LXEO) is positioned to show a strong performance in July 2026. The price is predicted to move between $8.45 and $8.95, settling at an average of $8.72. This could translate to a +111.14% gain.
August 2026
Based on current market signals, Lexeo Therapeutics, Inc. Common Stock is projected to trend august 2026. We forecast a trading range from $6.90 to $8.59, with a likely average price of $7.54. Investors could expect a potential return of +82.57%.
September 2026
Our predictive algorithms indicate Lexeo Therapeutics, Inc. Common Stock stock may see a shift in September 2026. The expected range spans $6.13–$7.94, with an average target of $7.18. This represents a positive outlook and a possible gain of +73.85%.
October 2026
Analyzing established trends, Lexeo Therapeutics, Inc. Common Stock looks set to move in October 2026. Projections place the stock between $6.00 and $8.47, averaging around $7.35. This suggests a +77.97% gain from current levels.
November 2026
Market indicators suggest Lexeo Therapeutics, Inc. Common Stock could experience notable changes during November 2026. Prices could fluctuate within $4.87 to $7.34, with a midpoint forecast of $6.16. The stock might deliver a +49.15% gain.
December 2026
Forecasting for December 2026, models estimate that Lexeo Therapeutics, Inc. Common Stock may undergo key fluctuations. If trends hold, the stock might trade between $5.65 and $8.58, averaging $7.65. This signals a positive trajectory with potential returns around +85.23%.
January 2027
According to our latest forecast models, Lexeo Therapeutics, Inc. Common Stock (LXEO) is positioned to show a strong performance in January 2027. The price is predicted to move between $3.85 and $7.87, settling at an average of $6.86. This could translate to a +66.10% gain.
February 2027
Based on current market signals, Lexeo Therapeutics, Inc. Common Stock is projected to trend february 2027. We forecast a trading range from $2.24 to $6.48, with a likely average price of $5.69. Investors could expect a potential return of +37.77%.
March 2027
Our predictive algorithms indicate Lexeo Therapeutics, Inc. Common Stock stock may see a shift in March 2027. The expected range spans $0.77–$4.73, with an average target of $4.23. This represents a positive outlook and a possible gain of +2.42%.
April 2027
Analyzing established trends, Lexeo Therapeutics, Inc. Common Stock looks set to move in April 2027. Projections place the stock between $0.10 and $3.16, averaging around $3.19. This suggests a -22.76% loss from current levels.
May 2027
Market indicators suggest Lexeo Therapeutics, Inc. Common Stock could experience notable changes during May 2027. Prices could fluctuate within $0.00 to $3.63, with a midpoint forecast of $3.89. The stock might deliver a -5.81% loss.
June 2027
Forecasting for June 2027, models estimate that Lexeo Therapeutics, Inc. Common Stock may undergo key fluctuations. If trends hold, the stock might trade between $0.00 and $3.07, averaging $3.80. This signals a cautious trajectory with potential returns around -7.99%.
July 2027
According to our latest forecast models, Lexeo Therapeutics, Inc. Common Stock (LXEO) is positioned to show a strong performance in July 2027. The price is predicted to move between $0.00 and $2.12, settling at an average of $3.07. This could translate to a -25.67% loss.
LXEO's history of dividends and stock splits also plays a role in long-term investor confidence.